Every now and then, a game-changing product comes along that tempts us to throw all other gadgets and glass out the window. The Stüdenglass gravity bong is one such product. Chances are you know of the bong through the viral video showing contemporary stoner icon Seth Rogen gripped by a coughing fit after one hit — cementing the bong’s place in counterculture legend.
The original product was conceived by ex-Apple alumni Tracey Huston, who filed the patent back in 2016. Recently, Stüdenglass was acquired by one of the most innovative — and coolest — cannabis companies, Grenco Science. Shortly after, Michael Trzecieski, founder of Vapium and tech-designer extraordinaire, took up the challenge of refining the state-of-the-art mounted gravity bong for top-shelf aficionados.
Cannabis Aficionado caught up with Trzecieski to talk about the synergies between weed and tech, how the Stüdenglass has improved, and, of course, that Seth Rogen video.
Cannabis Aficionado: Tell us about your journey through entrepreneurship and how you found your way to cannabis.
Michael Trzecieski: Growing up in Canada has afforded me many opportunities but there are two that have been the most formative — the first was becoming a Roboticist and the second was to witness and experience a country who showed true compassion toward cannabis as medicine. I was allowed to see the power of the plant without shame or indignity.
My journey as a Roboticist started in fibre optics, engineering micro-robotic toys. At the same time, Canada was making enormous strides towards full legalization. The timing, coupled with my desire to support the medical cannabis consumer, allowed me to shift my focus and passion — making a different kind of robot to support the people who needed it most. With this goal in mind, I took my years of experience in safety and controls (from toys being so heavily regulated) and applied this to making our first haptic vaporizer back in 2012.
Can you share your thoughts around the synergy between tech and cannabis?
Tech allows users to titrate their cannabis experience so they can choose to consume at various levels. Traditional methods of consumption are not always effective for all patients, and innovation is paramount for harm reduction and efficiencies. It is essential to have clean air intake, temperature stabilization. Temperature stabilization allows the vaporizing device to toast the leaf material instead of combusint it using a closed-loop temperature stabilization feedback system. At lower temperatures consumers can experience improved terpene profiles while at higher temperatures they may enjoy stronger effects.
What were the things you set out to achieve when designing the Stündenglass gravity bong?
The new Stündenglass glass gravity bong was designed for aesthetics, precision machining and cleaner vapor. We also wanted to provide a more comfortable user experience. Through the kinetic motion activation, vapours are sucked into an upper chamber and as water rushes from the upper chamber to lower chamber, the vapor percolates through the flowing water stream and offers vapour filtration as well as vapor cooling.
Tell us about the materials and why you chose them.
The materials chosen for the Stündenglass were predominantly glass and metal.
Glass offers a supreme taste, it is easy to clean, and it does not attract vapor and oil particles.
Stainless steel was also chosen as one of the core elements in the device because of its cleanliness as well as its ability to be precision-machined and for its high wearability in the valve portion of the device.
Anodized aluminium was also utilized for its durability and longevity.
What’s your favorite thing about the Stündenglass gravity bong?
It’s magical. The kinetic motion activation allows the device to both suck vapour as well as expel vapor at the same time, and provides percolation and water vapor filtration. There are also many magnetic components because magnets are also kind of magical.
Stündenglass was recently acquired by Grenco Science. Can you tell us details of how this exciting acquisition came about?
We first got to know Tracey Huston, and it was immediately apparent that there was a synergy between the brands, with a shared goal of innovation and improving upon the user experience. We recognized the ingenuity behind Stündenglass and understood how we could help by bringing this product into Grenco Science’s global expansion plan. From there it was a natural next step to bring Stündenglass into the Grenco Science umbrella.
How has the device evolved since its initial prototype?
The initial prototype was a very functional and utilitarian type unit. The design was since improved for its aesthetics, robustness, as well as the modularity. Furthermore, the percolation was an added feature and an improvement over the first model.
Subsequent models have allowed for modularity. The modules may be removed and taken apart, cleaned and accessorized, as well as replaced with other future potential attachments and improvements. A wall mount was also provided.
The viral video of Seth Rogen with his Stündenglass put the gravity bong on the wish-list of every aficionado, cementing its place in cannabis culture legend. How did it come about?
It was very organic. An early prototype was given to someone in Seth Rogen’s family, who then gave it to him. It was his own idea to create the video and share the experience online.
What tech trends do you predict for the cannabis industry over the next five years?
The bigger tech trends in the cannabis industry include dosing and data. Many customers want to be able to monitor their dosages as well as have data associated with their consumption, like what a Fitbit tracker does for fitness. This will allow producers to develop more meaningful formulations for their consumers as the data and dosing science evolves.
How do your products help shift the stigma about cannabis?
Our products help the ship the stigma on cannabis by bringing technology to the industry. This tech comes in the form of improved heating technologies, industrial design, safer material choices and temperature stabilized heating control loops.
In your opinion, what’s the most important thing that needs to be addressed when talking about cannabis?
That cannabis is a medicine. We are only beginning to uncover its real potential as legalization around the world grows.
How do you think the cannabis industry as a whole can be better?
Accountability. One of the major issues in the industry at the moment is a lack of accountability and a lack of safety and testing standards. There are still some operators that are looking to make a quick buck from unassuming consumers, and last year’s vape crisis was a direct result of that.
The cannabis industry is just in its beginning stages and needs to evolve. With this evolution there will be added accountability and more rules and regulations to ensure it’s safer for all.
What do you wish you knew when you started out in cannabis entrepreneurship?
I wish I knew that it was not going to be easy, and this holds true for any entrepreneurship. Finding the right people and putting together the right team is really important. It took us years to finally find the right partners and the right people to work with. This allowed us to evolve from a smaller operation to a larger entity.
Finally, what are three things it takes to be a cannabis entrepreneur?
I would say the first thing is creativity. You have to be full of ideas; you have to understand how to change the game; and how to make a difference, not just fit in. As the industry quickly evolves with ever changing rules and regulations, you need to keep your head in the game. It’s an industry for sharp minded entrepreneurs who know they can make a difference.
You’ve got to be tenacious, never take no for an answer, and keep on pushing for what you want to achieve going forward. No one’s going to do it for you. You need to drive your creativity home to others and have them believe in you.
You need to show up and be present in order to know what the industry is about. You need to be present at trade shows, events and gatherings where you can meet the right people in order to develop the right relationships.
Auxly’s third-quarter cannabis results offer two headlines that need to be read together. Net revenue increased 24 percent from a year earlier to C$49.5 million, while reported net income declined. The difference does not mean the sales growth disappeared; it reflects, in part, a comparison with a prior-year quarter containing a substantial one-time gain.
Auxly’s news release reports adjusted EBITDA of C$15.8 million, up 29 percent, and net income of C$13.6 million, compared with C$20.5 million a year earlier. Management notes that the 2025 comparison included a C$8.1 million after-tax gain related to the Imperial debenture settlement.
That creates a reason to examine the components of earnings rather than selecting whichever headline looks most dramatic. A settlement gain can raise reported profit without representing repeatable sales of cannabis. Conversely, removing selected items produces a different measure whose definition and reconciliation still need to be understood.
Adjusted EBITDA is not the same as net income, and neither is simply the amount of cash available for expansion. Auxly identifies adjusted EBITDA as a non-GAAP measure and directs readers to its reconciliation. The useful comparison is between consistently defined measures over time, with the excluded items visible.
The financial statements add a cash distinction
The interim statements report C$14.3 million of net cash provided by operating activities during the quarter. That differs from the C$14.8 million figure before working-capital changes highlighted in the announcement. Both can be accurate because they describe different stages of the cash-flow calculation.
Working capital includes movements in items such as receivables and inventory. A measure calculated before those movements helps isolate one aspect of performance, but it cannot answer every question about cash actually generated during the period. The statements provide the bridge between the two numbers.
At September 30, the statements show C$51.4 million in cash and cash equivalents. That is a balance at a particular date. It should not be confused with the quarter’s revenue, its net income or a promise that the entire balance will be spent on new production.
The statements also label the interim figures unaudited and explain that share and per-share amounts reflect the July 28 share consolidation. Those details matter when comparing old share counts or earnings per share, even though they do not change the basic story about cannabis sales.
Flower and pre-rolls remain central
The management discussion says dried flower and pre-roll products accounted for approximately 64 percent of quarterly net revenue, with the balance from the company’s other cannabis product categories. It attributes year-over-year sales growth to higher volumes across core products and improved flower pricing, partly offset by pressure on vape prices.
That is more informative for readers following the cannabis shelf than an undifferentiated growth percentage. Different formats can move in different directions at the same company. Higher total revenue does not establish that every product category gained pricing power or that every retailer saw the same demand.
The filing also describes the role of Auxly Leamington in cultivation and processing. An integrated production footprint can support supply, but its existence alone does not demonstrate consumer preference, product quality or a future sales result. Those claims require evidence beyond the size of a facility.
The previous quarter supplies context
Auxly’s August 13 second-quarter announcement reported C$45.8 million in net revenue and C$14.3 million in adjusted EBITDA. The third-quarter figures are higher than those earlier results, as well as higher than the year-earlier revenue and adjusted EBITDA comparisons. That is a useful check on the direction of the reported business.
Quarter-to-quarter changes are still different from a sustained trend. Product launches, customer ordering and seasonal patterns can affect individual periods. A single quarter does not establish the eventual return on a capital project or the success of an export strategy.
Our earlier coverage of Weedmaps’ tougher advertising quarter illustrated another part of the cannabis economy. The companies have different business models and reporting measures, so their results should not be treated as interchangeable signals for the whole industry.
For Auxly, the next useful tests are continued demand, cash generation after working-capital movements and the results of planned investments. The present filing supports a specific conclusion: cannabis revenue and several operating indicators improved, while the reported net-income comparison requires attention to last year’s exceptional items.
Illustrative warehouse stock photograph; not an Auxly facility or identified cannabis inventory. Photo: Russ Murray / Unsplash.
Charlotte’s Web Reports Lower CBD Sales but a Narrower Quarterly Operating Loss
The hemp-derived CBD company’s latest results show why lower revenue and an improving quarterly loss can coexist—and why neither resolves the policy outlook.
Charlotte’s Web reported a difficult sales quarter for its hemp-derived CBD business while narrowing its operating loss. Revenue for the three months ended September 30, 2026 was US$9.4 million, down 18.3 percent from a year earlier. Its operating loss narrowed to US$3.7 million from US$5.3 million, showing why the direction of sales and the direction of a loss do not always match.
The company announced the results November 12 and filed its quarterly report with the U.S. Securities and Exchange Commission. The release attributes weaker revenue primarily to California restrictions that took effect in July, reduced promotional discounting and softer demand in parts of the hemp-wellness market. Those explanations are management’s account of the quarter, rather than an independent measurement of every factor affecting CBD shoppers.
Less revenue does not automatically mean a larger loss
The company’s earnings release reports quarterly gross profit of about US$4.4 million, compared with US$4.5 million a year earlier, even as sales fell. Gross margin improved to 46.9 percent from 38.9 percent. Selling, general and administrative expenses declined to US$8.1 million from US$9.7 million.
A percentage margin and a dollar profit measure answer different questions. A company can retain a larger share of each sales dollar while bringing in fewer dollars overall. Lower expenses can then narrow the operating loss without putting the business into operating profit. That is the distinction these results require.
The announcement also identifies an inventory reserve linked to simplifying the product range. Readers should therefore resist interpreting a single margin percentage as a permanent new baseline. Product mix, pricing, manufacturing costs and inventory adjustments can all affect the calculation.
The quarterly filing keeps the periods straight
The Form 10-Q records quarterly revenue more precisely at US$9.393 million and a net loss of US$3.458 million. These rounded to the US$9.4 million revenue and US$3.5 million net loss in the announcement. An operating loss and a net loss are different lines of the accounts, not conflicting reports of one number.
The nine-month picture is also distinct from the latest quarter. The release reports a US$20.7 million net loss for the first nine months, including noncash items associated with the earlier debenture conversion. It would be misleading to describe an improved third-quarter operating loss as proof that every year-to-date earnings measure improved.
The filing shows US$11.364 million of cash and cash equivalents at September 30. Cash on that date is a financial-position measure, rather than sales or profit earned during the quarter. Looking at the income statement and cash-flow statement together gives a fuller picture than treating a positive cash balance as evidence of profitability.
Hemp policy remains part of the business story
Cannabis policy is directly relevant to this CBD company because the legal definition of hemp determines which products can use that route to market. The Congressional Research Service’s October 28 legal sidebar explains that the federal delay does not move every element of the new definition to the same date. It distinguishes the treatment of certain cannabinoids not naturally produced by the plant from provisions delayed until December 11.
That distinction is useful beyond one company. A hemp-derived label does not settle a product’s future legal status, and a federal deadline does not automatically override a state’s separate rules. Consumers and businesses need to identify the applicable product definition, ingredients and jurisdiction.
Charlotte’s Web’s October 28 announcement said it planned to hold a corporate update after December 11 rather than a November earnings call, seeking greater policy clarity before discussing its outlook. That is a communications plan, not evidence that Congress will produce the outcome the company prefers.
Product access and medical evidence are separate
A financial report from a CBD business does not establish that a product treats a disease or is appropriate for a particular person. Sales trends describe commercial activity. They do not measure a clinical benefit, and a discussion of future healthcare distribution should not be mistaken for a new drug approval or a general reimbursement entitlement.
Our coverage of Willie Nelson’s hemp-policy appeal addresses the public debate over access. Charlotte’s Web’s results supply a different perspective: how a company says restrictions, pricing decisions and expenses are affecting its accounts. The two stories illuminate different parts of the same policy uncertainty.
The next meaningful business signals will include the durability of any sales recovery, spending levels and the details of the legal framework actually in force. For now, the results show a smaller quarterly operating loss alongside lower CBD revenue. They do not yet resolve whether the company can turn that improvement into sustained growth and profitability.
Illustrative empty-bottle stock photograph; not Charlotte’s Web packaging or identified CBD products. Photo: Kelly Sikkema / Unsplash.
Portland is considering removing a city-code restriction on cannabis drive-through and walk-up sales, but the proposal has not become a new retail permission. The city’s record for Ordinance 2026-407 shows the November 10 City Life Committee item was continued, with December 8 listed as its next meeting date.
The proposal introduced by Mayor Keith Wilson combines two subjects: updating the language governing exterior sales windows and revising the way licensing-payment provisions appear in city code. For cannabis shoppers, the first is about how a purchase might be collected. For operators, the second concerns the timing and administration of license costs.
A retailer considering a physical alteration would still need to assess the property and any other applicable approvals. Removing one cannabis-specific sales restriction is not the same thing as approving a building project.
The window restriction is specific
Portland’s current marijuana licensing chapter bars sales from vendor carts, temporary structures, satellite locations and exterior openings such as drive-through facilities or walk-up windows. The proposed amendment would remove the exterior-opening language while retaining restrictions on those other kinds of sales locations.
That is narrower than allowing cannabis sales anywhere a customer can drive or walk. A licensed premises would still be a particular business location, subject to the rest of its applicable requirements. The change concerns a method of serving customers, not the disappearance of the licensing system.
City materials say the amendment would align Portland’s wording with Oregon rules that made on-site delivery a permanent option in September 2020, following temporary pandemic arrangements. That history helps explain why the debate is framed as an update to conflicting language rather than a brand-new statewide retail model.
Convenience does not mean on-site consumption
One important boundary remains in the proposed code exhibit: the provision against consumption on licensed premises is retained, with its existing narrow employee exception under Oregon law. A pickup window and a consumption lounge are different activities.
The same exhibit retains operating-hour and security requirements. Its redline shows a targeted deletion concerning sales openings, rather than an across-the-board removal of the rules governing retail premises. Reading the actual proposed changes is more informative than assuming that the phrase drive-through implies a completely different type of store.
For a customer, the practical questions would still include whether a specific retailer offers a service, how the order is handled and which rules apply. A citywide code amendment, if adopted, would not guarantee that every shop installs a window or changes its property layout.
The payment provisions affect operators differently
The ordinance also addresses the Deferred Payment Program for license fees. The city’s explanation says a 50% initial payment better supports collection and that the code should refer to the council-approved fee schedule rather than preserve outdated dollar amounts.
That is a distinction between the text of the code and the administration of a program. City materials say programmatic changes were communicated in June and July and implementation began in August. The proposal would codify practices already in place, according to the city, rather than introduce every payment change for the first time.
Operators evaluating the proposal therefore need both the amended text and the applicable fee schedule. A headline about pickup windows does not explain a business’s entire licensing bill, and an old fixed amount quoted from code may not describe current program administration.
Businesses are raising questions about cash flow
In KPTV’s November 10 reporting, Mikhala Armstrong described support for greater accessibility alongside concerns from cannabis operators about payment obligations and late fees. Those interviews add an important perspective to the city’s stated goal of improving administration.
The two views are not interchangeable. The city describes its intended program effects; individual operators describe how they believe the arrangements affect their businesses. A final assessment should distinguish those accounts from evidence about what happens after implementation.
Our coverage of Missouri’s interstate cannabis guidance concerned a separate jurisdiction, but illustrates a related point: legal cannabis markets remain governed by specific rules at different levels. A state allowance does not make every local detail irrelevant.
The next step is still a public decision
The city’s document history is the place to follow whether the committee advances or amends the proposal. As of this review, its status is continued, not adopted. Readers should check the updated agenda before relying on the December meeting listing or making plans to offer a new service.
The potential change is concrete: remove a particular restriction on how licensed cannabis stores serve customers and bring fee language into line with current administration. Whether that becomes the final city policy remains the question before Portland, rather than a decision already made.
Illustrative Portland waterfront photograph; not a dispensary or proposed pickup site. Photo: Meggyn Pomerleau / Unsplash.